Libo Si
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 4
- Cancer-related gene regulation 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Shuhai Li (19 shared papers)Cun Gao (17 shared papers)Weiming Yue (18 shared papers)Hui Tian (14 shared papers)Ming Lü (13 shared papers)Lei Qi (10 shared papers)Hui Tian (8 shared papers)Bin Hao (3 shared papers)
- Journals
- Medical Oncology (3 papers)PLoS ONE (3 papers)Acta Biochimica et Biophysica Sinica (2 papers)Oncology Reports (2 papers)Journal of Functional Foods (1 paper)
- Partner nations
- China
In The Last Decade
Libo Si
28 papers receiving 421 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 92
- Molecular Biology 248
- Geriatrics and Gerontology 8
- Pathology and Forensic Medicine 34
- Oncology 50
Countries citing papers authored by Libo Si
This map shows the geographic impact of Libo Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Si more than expected).
Fields of papers citing papers by Libo Si
This network shows the impact of papers produced by Libo Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Si. The network helps show where Libo Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 45 | |
| 2 | 2016 | 34 | |
| 3 | 2014 | 34 | |
| 4 | 2017 | 26 | |
| 5 | 2014 | 23 | |
| 6 | 2013 | 23 | |
| 7 | 2015 | 22 | |
| 8 | 2014 | 21 | |
| 9 | 2014 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2014 | 17 | |
| 12 | 2016 | 17 | |
| 13 | 2013 | 16 | |
| 14 | 2014 | 15 | |
| 15 | 2014 | 12 | |
| 16 | 2014 | 12 | |
| 17 | 2014 | 11 | |
| 18 | 2018 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2018 | 9 |
About Libo Si
Libo Si is a scholar working on Cancer Research, Molecular Biology, Oncology, Pathology and Forensic Medicine and Geriatrics and Gerontology, having authored 28 papers that have together received 426 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), Peptidase Inhibition and Analysis (5 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer-related gene regulation (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (92 citations), Molecular Biology (248 citations), Geriatrics and Gerontology (8 citations), Pathology and Forensic Medicine (34 citations) and Oncology (50 citations). Libo Si has collaborated with scholars based in China. Frequent co-authors include Shuhai Li, Cun Gao, Weiming Yue, Hui Tian, Ming Lü, Lei Qi, Hui Tian, Bin Hao, Lei Qi and Lin Li. Their work appears in journals such as Medical Oncology, PLoS ONE, Acta Biochimica et Biophysica Sinica, Oncology Reports and Journal of Functional Foods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.